MCAT BIO QUESTION: Difference between loss of heterozygosity, hemizygosity, and haploinsufficiency?

Here are some definitions straight from my TPR bio book. Would anyone be able to explain what the difference is between loss of heterozygosity, hemizygosity, and haploinsufficiency? Thank you!

https://preview.redd.it/58i4f7dw3fg31.png?width=773&format=png&auto=webp&s=36c115b64a0f2a5dbd0ef56adc3afd502f47d45b

πŸ‘︎ 5
πŸ’¬︎
πŸ‘€︎ u/MEDScienArtist
πŸ“…︎ Aug 14 2019
🚨︎ report
DNMT3A haploinsufficiency results in behavioral deficits and global epigenomic dysregulation shared across neurodevelopment disorders biorxiv.org/content/10.11…
πŸ‘︎ 2
πŸ’¬︎
πŸ‘€︎ u/sburgess86
πŸ“…︎ Jul 13 2020
🚨︎ report
CRISPR-mediated activation of promoter or enhancer rescues obesity caused by haploinsufficiency genengnews.com/news/crisp…
πŸ‘︎ 16
πŸ’¬︎
πŸ‘€︎ u/genengnews
πŸ“…︎ Dec 14 2018
🚨︎ report
ELI5: Haploinsufficiency and Hemizygosity. What are they and what is their relation or difference?
πŸ‘︎ 3
πŸ’¬︎
πŸ‘€︎ u/Natalier91
πŸ“…︎ Feb 01 2018
🚨︎ report
How to experimentally differentiate between haploinsufficiency and dominant negative effects?

Wondering about your thoughts on how to best distinguish between haploinsufficiency and dominant negative mechanisms through laboratory experiments. Haploinsufficiency would mean that there is less protein product so less protein complexes are formed but they are still functional. Dominant negative would either mean that the complexes don't form or there is less catalytic activity because the mutant protein is interfering with wild-type function. So would measuring the amount of protein complexes and activity differentiate between the two mechanisms? Thanks for the help!

πŸ‘︎ 8
πŸ’¬︎
πŸ‘€︎ u/shmelody
πŸ“…︎ Oct 03 2017
🚨︎ report
Haploinsufficiency of myostatin protects against aging-related declines in muscle function and enhances the longevity of mice onlinelibrary.wiley.com/e…
πŸ‘︎ 14
πŸ’¬︎
πŸ‘€︎ u/Lemming233
πŸ“…︎ Mar 27 2015
🚨︎ report
What is the difference between haploinsufficiency and dominant negative?

Is it that dominant negative mutated allele impacts the wild-type allele, and renders it inactive? Thus no wild-type function from the protein?

And is haploinsufficiency just that you have one wild-type allele, with the other one lost, but that one functional allele is not sufficient to promote the wild-type activity?

πŸ‘︎ 6
πŸ’¬︎
πŸ‘€︎ u/Mimi108
πŸ“…︎ Apr 23 2018
🚨︎ report
Haploinsufficiency of myostatin protects against aging-related declines in muscle function and enhances the longevity of mice onlinelibrary.wiley.com/e…
πŸ‘︎ 6
πŸ’¬︎
πŸ‘€︎ u/Lemming233
πŸ“…︎ Mar 27 2015
🚨︎ report
NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism nature.com/articles/s4146…
πŸ‘︎ 3
πŸ’¬︎
πŸ‘€︎ u/nliausacmmv
πŸ“…︎ Nov 15 2017
🚨︎ report
drug induced haploinsufficiency in yeast explained?

I have to a write report on a paper, and one of the experiments the authors are using is drug induced Haploinsufficiency in yeast to identify drug targets. If a yeast strain heterzygous for a target of the drug and is grown in the presence of the drug, apparently it doesn't grow as well at the WT yeast grown in the same concentration of drug.

Could anyone explain to me the biochemistry occurring here? Why are the heterozygous strains more sensitive to the drug, and why is the drug killing these more sensitive yeast strains? I understand that the heterozygous yeast strains have less of the drug target proteins, but what does that have to do with the yeast surviving or not?

πŸ‘︎ 3
πŸ’¬︎
πŸ‘€︎ u/steeleater01
πŸ“…︎ Oct 01 2017
🚨︎ report
Haploinsufficiency

Can someone give me a definition of what exactly haploinsufficiency means?

From What I understand it means that one good copy of a particular gene is not enough to produce a wild type phenotype in an organism. Could it also apply to deleterious alleles? For instance, could having one bad copy of the allele not be enough to develop the disease or would you have a moderately affected phenotype?

πŸ‘︎ 2
πŸ’¬︎
πŸ‘€︎ u/munger91
πŸ“…︎ Oct 28 2014
🚨︎ report
How to experimentally differentiate between haploinsufficiency and dominant negative effects?

Wondering about your thoughts on how to best distinguish between haploinsufficiency and dominant negative mechanisms through laboratory experiments. Haploinsufficiency would mean that there is less protein product so less protein complexes are formed but they are still functional. Dominant negative would either mean that the complexes don't form or there is less catalytic activity because the mutant protein is interfering with wild-type function. So would measuring the amount of protein complexes and activity differentiate between the two mechanisms?

Thanks for the help!

πŸ‘︎ 5
πŸ’¬︎
πŸ‘€︎ u/shmelody
πŸ“…︎ Oct 03 2017
🚨︎ report

Please note that this site uses cookies to personalise content and adverts, to provide social media features, and to analyse web traffic. Click here for more information.